Valneva

Valneva is owned by Groupe Grimaud. Groupe Grimaud has a direct presence in 3 countries.

Groupe Grimaud has 3 subsidiaries including Valneva, Valneva Austria and Valneva Canada.

They are in:

• Biotechnology50%
• Healthcare50%

View the org chart displaying its 25 main executives

Most searched biographies at Valneva

• Thomas Lingelbach, President and Chief Executive Officer
• James Sulat, Director
• Anne-Marie Graffin, Chairman of the Board

Popular executive movements at Valneva

• Anne-Marie Graffin, who was Director, is promoted to Chairman of the Board  (posted on December 21 2023).
• Sharon Tetlow, Director, will leave the company on Dec. 31, 2023  (posted on November 16 2023).
• Johanna Pattenier, Director, will leave the company on Dec. 20, 2023  (posted on November 16 2023).

Click here to view some more movements at Valneva

Create your alert
to follow the executive moves at Valneva.

Groupe Grimaud has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Valneva

• In The News – Valneva

Social media about Valneva

• Valneva on Wikipedia, Google News & Yahoo Finance
• Valneva on LinkedIn, Twitter & YouTube

Contact by email its executives including Thomas Lingelbach

Call Valneva at +33 47...

View the org chart

Register to receive your alert

Report an error